Dina Burkitbayeva

Dina Burkitbayeva has a diverse work experience spanning various industries and roles. In 2009, they started as an intern at LePatner & Associates, LLP, followed by an internship at White & Case in 2010. Dina then worked as an Investment Banking Analyst at J.P. Morgan in 2011 and as a Business Analyst at McKinsey & Company from 2012 to 2013. In 2015, Dina founded TRU Book and served as the CEO until 2018. From 2018 to 2020, they worked at Product School as the Head of Growth & Business Development. In 2020, they founded PsyMed Ventures, and they are currently the CEO & Co-founder of Freedom Biosciences since 2021.

Dina Burkitbayeva's education history can be summarized as follows:

Dina started their education at Cornell University, where they pursued a Bachelor of Science (B.S.) and Bachelor of Arts (B.A.) degree in City & Regional Planning and Economics. The specific dates of their enrollment at Cornell University are not provided.

Following their undergraduate studies, Dina attended Phillips Academy from 2002 to 2006, although details about the degree or field of study they pursued there are not mentioned.

In 2009, Dina enrolled at the University of Oxford for a one-year program called JYA (Junior Year Abroad), focusing on Politics, Philosophy, and Economics.

Later on, in 2013, they attended Harvard Business School, where they pursued a Master of Business Administration (MBA) degree. Dina'senrollment at Harvard lasted until 2015.

Dina also obtained a Web Development Certificate from Product School in August 2017. The exact duration of this certification program is not provided.

Currently, Dina is a PhD candidate in East West Psychology at the California Institute of Integral Studies, having commenced their studies in 2020. No specific completion date is mentioned for their doctorate degree.